Levels of YKL-40 in serum and sputum of patients diagnosed with hypersensitivity pneumonitis: A pilot study.
M. Cruz Carmona (Barcelona, Spain), M. De Homdedeu (Barcelona, Spain), S. Sanchez-Diez (Barcelona, Spain), I. Ojanguren (Barcelona, Spain), C. Romero-Mesones (Barcelona, Spain), A. Villar (Barcelona, Spain), F. Morell (Barcelona, Spain), X. MuñOz (Barcelona, Spain)
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Cruz Carmona (Barcelona, Spain), M. De Homdedeu (Barcelona, Spain), S. Sanchez-Diez (Barcelona, Spain), I. Ojanguren (Barcelona, Spain), C. Romero-Mesones (Barcelona, Spain), A. Villar (Barcelona, Spain), F. Morell (Barcelona, Spain), X. MuñOz (Barcelona, Spain). Levels of YKL-40 in serum and sputum of patients diagnosed with hypersensitivity pneumonitis: A pilot study.. 2961
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
YKL-40 and KL-6 in serum and sputum samples of patients diagnosed with hypersensitivity pneumonitis. Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases Year: 2019
Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Serum ECP in comparison to sputum ECP measurements in symptomatic and asymptomatic subjects with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis Source: Eur Respir J , 49 (2) 1501924; DOI: 10.1183/13993003.01924-2015 Year: 2017
Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study Source: ERJ Open Res, 4 (3) 00022-2018; 10.1183/23120541.00022-2018 Year: 2018
Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study Source: Eur Respir J, 55 (4) 1901983; 10.1183/13993003.01983-2019 Year: 2020
Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis Source: Eur Respir J 2007; 29: 706-712 Year: 2007
Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
Induced sputum and BAL from patients with hypersensitivity pneumonitis Source: Eur Respir J 2001; 18: Suppl. 33, 508s Year: 2001
Serum and sputum interleukin-8: comparison between normal and allergic asthmatics children Source: Eur Respir J 2003; 22: Suppl. 45, 175s Year: 2003
Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Serum levels of interleukin-18 in patients affected by allergic bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002
Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015
Serum Interleukin (IL)-6 levels in patients with severe asthma disease is associated with blood eosinophilia Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020
The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016
Serum KL-6 level is increased in patients with pneumocystis pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 101s Year: 2006
Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011
Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018